J. Bach
New England Journal of Medicine · 2001–2010
A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 15 researchers here, as inferred from the citation graph.
Who trusts J. Bach overall
- O. Levy
- Shimon Sakaguchi
- Tommi Vatanen
- A. Ascherio
- A. Danese
- Hsin-jung Wu
- Norman P. Li
- K. Munger
- Y. Lee
- Vardhman K. Rakyan
Papers from J. Bach's perspective
Ordered by how strongly the researchers J. Bach trusts endorse each paper. Same corpus, a different order for every researcher.
- NKT cells: facts, functions and fallacies. (Immunology today (Amsterdam. Regular ed.))
- Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. (Journal of Pediatric Gastroenterology and Nutrition - JPGN)
- Commensal Host-Bacterial Relationships in the Gut (Science)
- Toll-like receptor signalling (Nature reviews. Immunology)
- Toll-like receptors: critical proteins linking innate and acquired immunity (Nature Immunology)
- An obesity-associated gut microbiome with increased capacity for energy harvest (Nature)
- B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. (Immunity)
- Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus (Science)
- Leucine-rich repeats and pathogen recognition in Toll-like receptors. (Trends in immunology)
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease (Nature)
Their papers
- The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update (2010) — 1,175 citations
- Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. (2005) — 1,080 citations
- TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes (2003) — 656 citations
- The effect of infections on susceptibility to autoimmune and allergic diseases. (2002) — 2,688 citations
- Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes (2001) — 652 citations